SS&C Technologies Holdings earnings release, July 23, 2026
SS&C Technologies Releases Record Q2 2026 Financial Results
Q2 2026 GAAP revenue $1,695.7 million, up 10.3%, Fully Diluted GAAP Earnings Per Share $0.97, up 34.7%
Adjusted revenue $1,696.9 million, up 10.3%, Adjusted Diluted Earnings Per Share $1.76, up 18.1%
WINDSOR, CT, July 23, 2026 (BUSINESS WIRE)
--
SS&C Technologies Holdings, Inc. (NASDAQ: SSNC), a global provider of investment, financial and healthcare technology and technology-enabled services, today announced its financial results for the second quarter ended June 30, 2026.
Financial statements
Income Statement
Three Months Ended June 30, (in millions, except per share data)
| Three Months Ended June 30, – 2026 | Three Months Ended June 30, – 2025 | Change | Six Months Ended June 30, – 2026 | Six Months Ended June 30, – 2025 | Change | ||
|---|---|---|---|---|---|---|---|
| GAAP Results | Revenue | 1,695.7 | 1,536.8 | 10.3% | 3,342.8 | 3,050.7 | 9.6% |
| GAAP Results | Operating income | 417.1 | 344.5 | 21.1% | 815.3 | 702.4 | 16.1% |
| GAAP Results | Operating income margin | 24.6% | 22.4% | 220 bps | 24.4% | 23.0% | 140 bps |
| GAAP Results | Net income | 234.8 | 180.8 | 29.9% | 460.9 | 393.8 | 17.0% |
| GAAP Results | Diluted earnings per share | 0.97 | 0.72 | 34.7% | 1.88 | 1.55 | 21.3% |
| Adjusted Non-GAAP Results (defined in Notes 1 - 4 below) | Adjusted revenue | 1,696.9 | 1,537.8 | 10.3% | 3,345.1 | 3,052.6 | 9.6% |
| Adjusted Non-GAAP Results (defined in Notes 1 - 4 below) | Adjusted operating income | 653.8 | 583.5 | 12.0% | 1,287.4 | 1,158.8 | 11.1% |
| Adjusted Non-GAAP Results (defined in Notes 1 - 4 below) | Adjusted operating income margin | 38.5% | 37.9% | 60 bps | 38.5% | 38.0% | 50 bps |
| Adjusted Non-GAAP Results (defined in Notes 1 - 4 below) | Adjusted consolidated EBITDA | 670.7 | 600.4 | 11.7% | 1,321.7 | 1,192.3 | 10.9% |
| Adjusted Non-GAAP Results (defined in Notes 1 - 4 below) | Adjusted consolidated EBITDA margin | 39.5% | 39.0% | 50 bps | 39.5% | 39.1% | 40 bps |
| Adjusted Non-GAAP Results (defined in Notes 1 - 4 below) | Adjusted diluted earnings per share(1) | 1.76 | 1.49 | 18.1% | 3.45 | 2.97 | 16.2% |
Income Statement
Guidance
| Q3 2026 | FY 2026 | |
|---|---|---|
| Adjusted Revenue ($M) | $1,657 – $1,697 | $6,672 – $6,832 |
| Adjusted Net Income ($M) | $413 – $429 | $1,670 – $1,770 |
| Interest Expense1 ($M) | $103 – $105 | $406 – $416 |
| Adjusted Diluted Earnings per Share | $1.73 – $1.79 | $6.93 – $7.25 |
| Cash from Operating Activities ($M) | $1,717 – $1,817 | |
| Capital Expenditures (% of revenue) | 4.4% – 4.8% | |
| Diluted Shares (M) | 237.6 – 240.6 | 241.0 – 244.0 |
| Effective Income Tax Rate (%) | 21.5% – 23.5% | 21.5% – 23.5% |
Income Statement
Three Months Ended June 30, — (unaudited) (in millions)
| Three Months Ended June 30, – 2026 | Three Months Ended June 30, – 2025 | Six Months Ended June 30, – 2026 | Six Months Ended June 30, – 2025 | ||
|---|---|---|---|---|---|
| Revenues: | Technology-enabled services | 1,408.2 | 1,267.7 | 2,815.5 | 2,537.6 |
| Revenues: | License, maintenance and related | 287.5 | 269.1 | 527.3 | 513.1 |
| Revenues: | Total revenues | 1,695.7 | 1,536.8 | 3,342.8 | 3,050.7 |
| Cost of revenues: | Technology-enabled services | 771.6 | 693.9 | 1,512.1 | 1,361.2 |
| Cost of revenues: | License, maintenance and related | 105.8 | 106 | 210.6 | 205.5 |
| Cost of revenues: | Total cost of revenues | 877.4 | 799.9 | 1,722.7 | 1,566.7 |
| Cost of revenues: | Gross profit | 818.3 | 736.9 | 1,620.1 | 1,484 |
| Operating expenses: | Selling and marketing | 160.5 | 152.4 | 312.2 | 304.7 |
| Operating expenses: | Research and development | 132.3 | 128.1 | 266.9 | 257.2 |
| Operating expenses: | General and administrative | 108.4 | 111.9 | 225.7 | 219.7 |
| Operating expenses: | Total operating expenses | 401.2 | 392.4 | 804.8 | 781.6 |
| Operating expenses: | Operating income | 417.1 | 344.5 | 815.3 | 702.4 |
| Operating expenses: | Interest expense, net | -107 | -105.5 | -212.4 | -210.7 |
| Operating expenses: | Other income (expense), net | 1.1 | -1.1 | 7.9 | 6.1 |
| Operating expenses: | Equity in earnings of unconsolidated affiliates, net | 3 | 1.6 | 6.9 | 3.9 |
| Operating expenses: | Loss on extinguishment of debt | -0.4 | -0.9 | ||
| Operating expenses: | Income before income taxes | 314.2 | 239.5 | 617.3 | 500.8 |
| Operating expenses: | Provision for income taxes | 78.9 | 58.4 | 155.7 | 106.5 |
| Operating expenses: | Net income | 235.3 | 181.1 | 461.6 | 394.3 |
| Operating expenses: | Net income attributable to noncontrolling interest | -0.5 | -0.3 | -0.7 | -0.5 |
| Operating expenses: | Net income attributable to SS&C common stockholders | 234.8 | 180.8 | 460.9 | 393.8 |
| Operating expenses: | Basic earnings per share attributable to SS&C common stockholders | 0.99 | 0.74 | 1.92 | 1.6 |
| Operating expenses: | Diluted earnings per share attributable to SS&C common stockholders | 0.97 | 0.72 | 1.88 | 1.55 |
| Operating expenses: | Basic weighted-average number of common shares outstanding | 238.1 | 244.9 | 239.8 | 245.4 |
| Operating expenses: | Diluted weighted-average number of common and common equivalent shares outstanding | 242 | 252.2 | 244.6 | 253.5 |
| Operating expenses: | Net income | 235.3 | 181.1 | 461.6 | 394.3 |
| Other comprehensive (loss) income, net of tax: | Foreign currency exchange translation adjustment | -2.6 | 207.8 | -74.7 | 300.3 |
| Other comprehensive (loss) income, net of tax: | Change in defined benefit pension obligation | -0.2 | 0.2 | ||
| Other comprehensive (loss) income, net of tax: | Total other comprehensive (loss) income, net of tax | -2.8 | 207.8 | -74.5 | 300.3 |
| Other comprehensive (loss) income, net of tax: | Comprehensive income | 232.5 | 388.9 | 387.1 | 694.6 |
| Other comprehensive (loss) income, net of tax: | Comprehensive income attributable to noncontrolling interest | -0.5 | -0.3 | -0.7 | -0.5 |
| Other comprehensive (loss) income, net of tax: | Comprehensive income attributable to SS&C common stockholders | 232 | 388.6 | 386.4 | 694.1 |
Income Statement
Three Months Ended June 30, (in millions)
| Three Months Ended June 30, – 2026 | Three Months Ended June 30, – 2025 | Six Months Ended June 30, – 2026 | Six Months Ended June 30, – 2025 | |
|---|---|---|---|---|
| Technology-enabled services | 1,408.2 | 1,267.7 | 2,815.5 | 2,537.6 |
| License, maintenance and related | 287.5 | 269.1 | 527.3 | 513.1 |
| Total revenues | 1,695.7 | 1,536.8 | 3,342.8 | 3,050.7 |
| Technology-enabled services | 1,409.4 | 1,268.7 | 2,817.8 | 2,539.5 |
| License, maintenance and related | 287.5 | 269.1 | 527.3 | 513.1 |
| Total adjusted revenues | 1,696.9 | 1,537.8 | 3,345.1 | 3,052.6 |
Income Statement
Three Months Ended June 30, (in millions)
| Three Months Ended June 30, – 2026 | Three Months Ended June 30, – 2025 | Six Months Ended June 30, – 2026 | Six Months Ended June 30, – 2025 | Twelve Months Ended June 30, – 2026 | |
|---|---|---|---|---|---|
| Net income | 235.3 | 181.1 | 461.6 | 394.3 | 866 |
| Interest expense, net | 107 | 105.5 | 212.4 | 210.7 | 428 |
| Provision for income taxes | 78.9 | 58.4 | 155.7 | 106.5 | 225.4 |
| Depreciation and amortization | 180.9 | 174.9 | 361.9 | 345.7 | 720 |
| EBITDA | 602.1 | 519.9 | 1,191.6 | 1,057.2 | 2,239.4 |
| Stock-based compensation | 62 | 60.2 | 123.7 | 112.9 | 268.5 |
| Acquired EBITDA and cost savings (1) | 18.5 | ||||
| Equity in earnings of unconsolidated affiliates, net | -3 | -1.6 | -6.9 | -3.9 | 6.4 |
| Investment gains (2) | -2.8 | -0.9 | -11.5 | -10.2 | -15.4 |
| Facilities and workforce restructuring | 9.4 | 17.1 | 18.6 | 24.2 | 39.5 |
| Acquisition related | 0.6 | 1.7 | 1.5 | 3 | 10.1 |
| Other (3) | 4 | 4.9 | 7.5 | 11 | 47.5 |
| Consolidated EBITDA | 672.3 | 601.3 | 1,324.5 | 1,194.2 | 2,614.5 |
| Acquired EBITDA and cost savings (1) | -18.5 | ||||
| Adjusted Consolidated EBITDA | 672.3 | 601.3 | 1,324.5 | 1,194.2 | 2,596 |
| Adjusted Consolidated EBITDA attributable to noncontrolling interest (4) | -1.6 | -0.9 | -2.8 | -1.9 | -4.1 |
| Adjusted Consolidated EBITDA attributable to SS&C common stockholders | 670.7 | 600.4 | 1,321.7 | 1,192.3 | 2,591.9 |
Income Statement
Three Months Ended June 30, (in millions, except per share data)
| Three Months Ended June 30, – 2026 | Three Months Ended June 30, – 2025 | Six Months Ended June 30, – 2026 | Six Months Ended June 30, – 2025 | |
|---|---|---|---|---|
| GAAP – Net income | 235.3 | 181.1 | 461.6 | 394.3 |
| Amortization of intangible assets | 163.3 | 157 | 326.2 | 310 |
| Stock-based compensation | 62 | 60.2 | 123.7 | 112.9 |
| Equity in earnings of unconsolidated affiliates, net | -3 | -1.6 | -6.9 | -3.9 |
| Investment (gains) losses (1) | -1.8 | 1.7 | -1.3 | 3.5 |
| Facilities and workforce restructuring | 9.4 | 17.1 | 18.6 | 24.2 |
| Acquisition related | 0.6 | 1.7 | 1.5 | 3 |
| Other (2) | 6.5 | 7.8 | 12.6 | 16.7 |
| Income tax effect (3) | -45.1 | -48 | -89.9 | -106.3 |
| Adjusted net income | 427.2 | 377 | 846.1 | 754.4 |
| Adjusted net income attributable to noncontrolling interest (4) | -1.6 | -1.4 | -2.8 | -2.7 |
| Adjusted net income attributable to SS&C common stockholders | 425.6 | 375.6 | 843.3 | 751.7 |
| Adjusted diluted earnings per share attributable to SS&C common stockholders | 1.76 | 1.49 | 3.45 | 2.97 |
| GAAP diluted earnings per share attributable to SS&C common stockholders | 0.97 | 0.72 | 1.88 | 1.55 |
| Diluted weighted-average shares outstanding | 242 | 252.2 | 244.6 | 253.5 |
Balance Sheet
December 31, — (unaudited) (in millions)
| June 30, – 2026 | December 31, – 2025 | ||
|---|---|---|---|
| Current assets: | Cash and cash equivalents | 434.8 | 462.1 |
| Current assets: | Funds receivable and funds held on behalf of clients | 3,984.5 | 3,799.5 |
| Current assets: | Accounts receivable, net | 1,023.6 | 978.7 |
| Current assets: | Contract asset | 41 | 49.2 |
| Current assets: | Prepaid expenses and other current assets | 213.4 | 193.7 |
| Current assets: | Restricted cash | 2.3 | 4.5 |
| Current assets: | Total current assets | 5,699.6 | 5,487.7 |
| Current assets: | Property, plant and equipment, net | 265.3 | 289.5 |
| Current assets: | Operating lease right-of-use assets | 214.6 | 233.3 |
| Current assets: | Investments | 174.6 | 174.4 |
| Current assets: | Unconsolidated affiliates | 295.3 | 307.7 |
| Current assets: | Contract asset | 155.4 | 133.1 |
| Current assets: | Goodwill | 9,930 | 9,991.3 |
| Current assets: | Intangible and other assets, net | 3,873.8 | 4,094.7 |
| Current assets: | Total assets | 20,608.6 | 20,711.7 |
| Current liabilities: | Current portion of long-term debt | 265 | 25 |
| Current liabilities: | Client funds obligations | 3,984.5 | 3,799.5 |
| Current liabilities: | Accounts payable | 62.6 | 87.2 |
| Current liabilities: | Income taxes payable | 23.3 | |
| Current liabilities: | Accrued employee compensation and benefits | 233.5 | 348.9 |
| Current liabilities: | Interest payable | 32.1 | 31.6 |
| Current liabilities: | Other accrued expenses | 290.1 | 303.4 |
| Current liabilities: | Deferred revenue | 486.4 | 492.4 |
| Current liabilities: | Total current liabilities | 5,354.2 | 5,111.3 |
| Current liabilities: | Long-term debt, net of current portion | 7,312.2 | 7,408.4 |
| Current liabilities: | Operating lease liabilities | 200.1 | 213.2 |
| Current liabilities: | Other long-term liabilities | 193.8 | 190.2 |
| Current liabilities: | Deferred income taxes | 837.8 | 846.8 |
| Current liabilities: | Total liabilities | 13,898.1 | 13,769.9 |
| Current liabilities: | SS&C stockholders' equity | 6,640.7 | 6,887.6 |
| Current liabilities: | Noncontrolling interest | 69.8 | 54.2 |
| Current liabilities: | Total equity | 6,710.5 | 6,941.8 |
| Current liabilities: | Total liabilities and equity | 20,608.6 | 20,711.7 |
Cash Flow
Six Months Ended June 30, — (unaudited) (in millions)
| Six Months Ended June 30, – 2026 | Six Months Ended June 30, – 2025 | ||
|---|---|---|---|
| Cash flow from operating activities: | Net income | 461.6 | 394.3 |
| Adjustments to reconcile net income to net cash provided by operating activities: | Depreciation and amortization | 361.9 | 345.7 |
| Adjustments to reconcile net income to net cash provided by operating activities: | Equity in earnings of unconsolidated affiliates, net | -6.9 | -3.9 |
Full release
(1) Reflects non-GAAP tax rates of 22.5% for the three and six months ended June 30, 2026 and 22.0% for the three and six months ended June 30, 2025. See Note 4 for more information.
Second Quarter 2026 Highlights:
• Q2 2026 GAAP Revenue growth and Adjusted Revenue growth were 10.3 percent.
• Q2 2026 Adjusted Organic Revenue Growth was 7.6 percent.
• Net cash generated from operating activities of $716.4 million for the six months ended June 30, 2026, up 11.1 percent compared to the same period in 2025.
• Returned $499.2 million to shareholders in Q2 2026, which included a record 6.4 million shares repurchased for $435.2 million and $64.0 million in common stock dividends.
• Record adjusted consolidated EBITDA of $670.7 million for Q2 2026, up 11.7 percent. Adjusted consolidated EBITDA margin for Q2 2026 was 39.5 percent.
• GAAP operating income margin for Q2 2026 was 24.6 percent and GAAP net income of $234.8 million for Q2 2026, up 29.9 percent.
• Adjusted diluted earnings per share was $1.76, up 18.1 percent.
• We look forward to hosting our clients at SS&C Deliver in Orlando, FL September 20-22, 2026.
“SS&C delivered another record quarter, organic growth of 7.6 percent, adjusted revenues of $1,697 million and adjusted consolidated EBITDA of $671 million. These numbers were driven by consistent execution,” says Bill Stone, Chairman and Chief Executive Officer. “The structural advantages of SS&C's business model are reflected in the metrics that matter most: strong sales, robust renewal performance, healthy retention, and steady margin expansion. Our clients continue to invest in the relationship because our expertise, technology, and innovation are essential to their operations. Year to date, we returned 100 percent of allocated capital to shareholders through share repurchases and dividends, reflecting our confidence in the long-term value of our business.”¹
Operating Cash Flow
SS&C generated net cash from operating activities of $716.4 million for the six months ended June 30, 2026, compared to $645.1 million for the same period in 2025, a 11.1% increase. SS&C ended the second quarter with $434.8 million in cash and cash equivalents and $7,613.5 million in gross debt. SS&C’s consolidated net leverage ratio as defined in our credit agreement stood at 2.75 times consolidated EBITDA as of June 30, 2026. SS&C’s net secured leverage ratio stood at 1.70 times consolidated EBITDA as of June 30, 2026.
Guidance¹
Interest expense is net of deferred financing cost amortization and original issue discount
SS&C does not provide reconciliations of guidance for Adjusted Revenues and Adjusted Net Income to comparable GAAP measures, in reliance on the unreasonable efforts exception provided under Item 10(e)(1)(i)(B) of Regulation S-K. SS&C is unable, without unreasonable efforts, to forecast certain items required to develop meaningful comparable GAAP financial measures. These items include acquisition transactions and integration, foreign exchange rate changes, as well as other non-cash and other adjustments as defined under the Company’s Credit agreement, that are difficult to predict in advance in order to include in a GAAP estimate. The unavailable information could have a significant impact on Q3 2026 and FY 2026 GAAP financial results.
Non-GAAP Financial Measures
Adjusted revenue, adjusted operating income, adjusted consolidated EBITDA, adjusted net income and adjusted diluted earnings per share are non-GAAP measures. See the accompanying notes for the reconciliations and definitions for each of these non-GAAP measures and the reasons our management believes these measures provide useful information to investors regarding our financial condition and results of operations. All references above to net income, diluted earnings per share, adjusted operating income, adjusted consolidated EBITDA, and adjusted diluted earnings per share are attributable to SS&C.²
Earnings Call and Press Release
SS&C’s second quarter 2026 earnings call will take place at 5:00 p.m. eastern time today, July 23, 2026. The call will discuss second quarter 2026 results. Interested parties may visit investor.ssctech.com to access the live webcast and view accompanying slides. The call will be available for replay via the webcast on SS&C’s website; access: https://investor.ssctech.com/financials/quarterly-results/default.aspx... (truncated)ments, although not all forward-looking statements are accompanied by such words. Such statements reflect management’s best judgment based on factors currently known but are subject to risks and uncertainties, which could cause actual results to differ materially from those anticipated. Such risks and uncertainties include, but are not limited to, the state of the economy and the financial services industry and other industries in which the Company’s clients operate, the Company’s ability to realize anticipated benefits from its acquisitions, the effect of customer consolidation on demand for the Company’s products and services, the variability of revenue as a result of activity in the securities markets, the focus of the Company’s business on the asset management industry, the ability to retain and attract clients, the intensity of competition with respect to the Company’s products and services, risks from cyber-attacks, breaches of digital security, IT system failures and network disruptions, risks associated with third party providers, fluctuations in the Company’s operating results, terrorist activities and other catastrophic events, risks associated with the Company’s foreign operations, privacy concerns relating to the collection and storage of personal information, evolving regulations and increased scrutiny from regulators, the Company’s ability to protect intellectual property assets and litigation regarding intellectual property rights, delays in product development, investment decisions concerning cash balances, tax risks, risks associated with the Company’s joint ventures, changes in accounting standards, evolving regulation and scrutiny from regulators, the Company’s exposure to litigation and other claims, risks related to the Company’s substantial indebtedness, and the market price of the Company’s stock prevailing from time to time, and the risks discussed in the “Risk Factors” section of the Company’s most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q, which are on file with the Securities and Exchange Commission and can also be accessed on our website. Such “Risk Factors”, among others, could cause actual results to differ materially from those indicated by forward-looking statements made herein and presented elsewhere by management from time to time. Undue reliance should not be placed on any such forward-looking statements. Forward-looking statements speak only as of the date on which they are made and, except to the extent required by applicable securities laws, we undertake no obligation to update or revise any forward-looking statements.³
About SS&C Technologies
SS&C is a leading provider of mission-critical, AI-powered technology and services empowering financial services and healthcare organizations to work smarter, faster, and securely. Founded in 1986, SS&C is headquartered in Windsor, Connecticut, and has offices worldwide. More than 23,000 financial services and healthcare organizations, from the world's largest companies to small and mid-market firms, rely on SS&C for expertise, scale and technology.
Follow SS&C on Twitter, LinkedIn and Facebook.
For more information
Brian Schell
Chief Financial Officer
Tel: +1-816-642-0915
E-mail:
InvestorRelations@sscinc.com
Justine Stone
Head of Investor Relations
Tel: +1-212-367-4705
E-mail:
InvestorRelations@sscinc.com
Chand Madaka
Investor Relations
Tel: +1-908-845-1259
E-mail:
InvestorRelations@sscinc.com⁴
SS&C Technologies Holdings, Inc. and Subsidiaries
Condensed Consolidated Statements of Comprehensive Income
(in millions, except per share data)
(unaudited)⁵
SS&C Technologies Holdings, Inc. and Subsidiaries
Condensed Consolidated Balance Sheets
(in millions)
(unaudited)⁶
SS&C Technologies Holdings, Inc. and Subsidiaries
Condensed Consolidated Statements of Cash Flows
(in millions)
(unaudited)⁷
SS&C Technologies Holdings, Inc. and Subsidiaries
Disclosures Relating to Non-GAAP Financial Measures
Note 1. Reconciliation of Revenues to Adjusted Revenues
Adjusted revenues represents revenues adjusted to include a) amounts that would have been recognized if deferred revenue were not adjusted to fair value at the date of acquisition and b) amounts that would have been recognized if not for adjustments to deferred revenue and retained earnings related to the adoption of ASC 606. Adjusted revenues is presented because we use this measure to evaluate performance of our business against prior periods and believe it is a useful indicator of the underlying performance of our business. Adjusted revenues is not a recognized term under generally accepted accounting principles (“GAAP”). Adjusted revenues does not represent revenues, as that term is defined under GAAP, and should not be considered as an alternative to revenues as an indicator of our operating performance. Adjusted revenues as presented herein is not necessarily comparable to similarly titled measures presented by other companies. Below is a reconciliation of adjusted revenues to revenues, the GAAP measure we believe to be most directly comparable to adjusted revenues.
The following is a breakdown of technology-enabled services and license, maintenance and related revenues and adjusted technology-enabled services and license, maintenance and related revenues.⁸
Note 2. Reconciliation of Operating Income to Adjusted Operating Income... (truncated)indicator of our underlying performance. Adjusted operating income is not a recognized term under GAAP. Adjusted operating income does not represent operating income, as that term is defined under GAAP, and should not be considered as an alternative to operating income as an indicator of our operating performance. Adjusted operating income as presented herein is not necessarily comparable to similarly titled measures by other companies. The following is a reconciliation between adjusted operating income and operating income, the GAAP measure we believe to be most directly comparable to adjusted operating income.
(1)
Other includes additional expenses and income that are permitted to be excluded per the terms of our Credit Agreement from Consolidated EBITDA, a financial measure used in calculating our covenant compliance.
(2)
Adjusted operating income attributable to noncontrolling interest represents the proportionate share of adjusted operating income of DomaniRx, LLC (a consolidated joint venture) retained by our joint venture partners.⁹
Note 3. Reconciliation of Net Income to EBITDA, Consolidated EBITDA and Adjusted Consolidated EBITDA
EBITDA represents net income before interest expense, income taxes, depreciation and amortization. Consolidated EBITDA, defined under our Credit Agreement entered into in April 2018, as amended, is used in calculating covenant compliance, and is EBITDA adjusted for certain items. Consolidated EBITDA is calculated by subtracting from or adding to EBITDA items of income or expense described below. Adjusted Consolidated EBITDA is calculated by subtracting acquired EBITDA (as defined below) from Consolidated EBITDA. EBITDA, Consolidated EBITDA and Adjusted Consolidated EBITDA are presented because we use these measures to evaluate performance of our business and believe them to be useful indicators of an entity’s debt capacity and its ability to service debt. EBITDA, Consolidated EBITDA and Adjusted Consolidated EBITDA are not recognized terms under GAAP and should not be considered in isolation or as alternatives to operating income, net income or cash flows from operating activities as indicators of our operating performance. These measures are not necessarily comparable to similarly titled measures by other companies. The following is a reconciliation of EBITDA, Consolidated EBITDA and Adjusted Consolidated EBITDA to net income.
(1)
Acquired EBITDA reflects the EBITDA impact of significant businesses that were acquired during the last twelve months as if the acquisition occurred at the beginning of the trailing twelve-month period, as well as cost savings enacted in connection with acquisitions.
(2)
Investment gains includes unrealized fair value adjustments of investments and dividend income received on investments.
(3)
Other includes additional expenses and income that are permitted to be excluded per the terms of our Credit Agreement from Consolidated EBITDA, a financial measure used in calculating our covenant compliance, and includes a loss on the sale of fixed assets of $33.3 million during the twelve months ended June 30, 2026.
(4)
Adjusted Consolidated EBITDA attributable to noncontrolling interest represents the proportionate share of adjusted Consolidated EBITDA of DomaniRx, LLC (a consolidated joint venture) retained by our joint venture partners.¹⁰
Note 4. Reconciliation of Net Income to Adjusted Net Income and Diluted Earnings Per Share Attributable to SS&C to Adjusted Diluted Earnings Per Share Attributable to SS&C
Adjusted net income and adjusted diluted earnings per share attributable to SS&C represent net income and earnings per share attributable to SS&C before amortization of intangible assets and deferred financing costs, stock-based compensation, purchase accounting adjustments and other items. We consider adjusted net income and adjusted diluted earnings per share attributable to SS&C to be important to management and investors because they represent our operational performance exclusive of the effects of amortization of intangible assets and deferred financing costs, stock-based compensation, purchase accounting adjustments, loss on extinguishment of debt and other items, that are not operational in nature or comparable to those of our competitors. Adjusted net income and adjusted diluted earnings per share are not recognized terms under GAAP. Adjusted net income and adjusted diluted earnings per share do not represent net income or diluted earnings per share, as those terms are defined under GAAP, and should not be considered as alternatives to net income or diluted earnings per share as indicators of our operating performance. Adjusted net income and adjusted diluted earnings per share attributable to SS&C as presented herein are not necessarily comparable to similarly titled measures presented by other companies. Below is a reconciliation of adjusted net income and adjusted diluted earnings per share attributable to SS&C to net income and diluted earnings per share attributable to SS&C, the GAAP measures we believe to be most directly comparable to adjusted net income and adjusted diluted earnings per share.
(1)
Investment (gains) losses includes unrealized fair value adjustments of investments.
(2)
Other includes additional expenses and income that are permitted to be excluded per the terms of our Credit Agreement from Consolidated EBITDA, a financial measure used in calculating our covenant compliance.
(3)
An estimated effective tax rate of 22.5% has been used to adjust the provision for income taxes for the purpose of computing adjusted net income for the three and six months ended June 30, 2026. An effective tax rate of 22% has been used to retroactively adjust the provision for income taxes for the purpose of computing adjusted net income for the three and six months ended June 30, 2025.
(4)... (truncated)ents the proportionate share of adjusted net income of DomaniRx, LLC (a consolidated joint venture) retained by our joint venture partners.¹¹